MIRA
INFORM REPORT
|
Report Date : |
31.05.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MEDICO REMEDIES PRIVATE LIMITED |
|
|
|
|
Registered Office : |
50, Juhu Supreme Shopping Center, Gulmohar Cross Road No. 9, Juhu,
Mumbai 400049, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
18.03.1994 |
|
|
|
|
Com. Reg. No.: |
077187 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24230MH1994PTC077187 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMM22132F |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCM8349L |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 72000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and reputed company meeting its normal commitments timeously. Trade relations are fair. The company can be considered good for normal business dealings |
INFORMATION PARTED
BY
|
Name : |
Mr. Harshit Mehta |
|
Designation : |
Technical Director |
|
Date : |
29.05.2008 |
LOCATIONS
|
Registered Office : |
50, Juhu Supreme Shopping Center, Gulmohar Cross Road No. 9, Juhu,
Mumbai 400049, Maharashtra, India |
|
Tel. No.: |
91-22-26701055 / 26701066 |
|
Fax No.: |
91-22-26281059 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
400 Sq. fts. |
|
Location : |
Owned |
|
|
|
|
Factory 1 : |
9, Dewan & Sons Udyog Nagar, Palghar (West), Thane, Maharashtra,
India |
|
Tel. No.: |
91-952525-252868 / 256381 |
|
Fax No.: |
91-952525-255287 |
DIRECTORS
|
Name : |
Mr. Haresh Kapurlal Mehta |
|
Designation : |
Director |
|
Address : |
5-A, Pleasant Palace, N. S. Road, JVPD Scheme, Mumbai 400049,
Maharashtra, India |
|
Date of Birth/Age : |
17.08.1955 |
|
Qualification : |
B. Pharma |
|
Date of Appointment : |
18.03.1994 |
|
|
|
|
Name : |
Mrs. Rita Haresh Mehta |
|
Designation : |
Director |
|
Address : |
5-A, Pleasant Palace, N. S. Road, JVPD Scheme, Mumbai 400049, Maharashtra,
India |
|
Date of Birth/Age : |
20.10.1960 |
|
Qualification : |
B.Com |
|
Date of Appointment : |
08.12.1999 |
|
|
|
|
Name : |
Mr. Raichand C. Shah |
|
Designation : |
Director |
|
Address : |
51A, Roop Darshan, Andheri [West], Mumbai 400056, Maharashtra, India |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
[As on 30.09.2005]
|
Names of Shareholders |
|
No. of Shares |
|
Haresh Mehta |
|
240500 |
|
Rita Mehta |
|
129700 |
|
Mahendra Mehta |
|
13000 |
|
Haresh Mehta |
|
109800 |
|
Harshit Mehta |
|
7000 |
|
|
|
|
|
Equity Share
Break-up [As on 31.03.2007] |
|
Percentage of
Holding |
|
Directors or relatives of the Directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacture of Pharmaceutical Products |
|
|
|
|
Products : |
·
Tablets ·
Capsules ·
Suspensions |
|
|
|
|
Exports : |
|
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Credit |
|
|
|
|
Purchasing : |
Credit |
GENERAL
INFORMATION
|
Customers : |
|
|
|
|
|
No. of Employees : |
100 |
|
|
|
|
Bankers : |
Bank of Baroda |
|
|
|
|
Facilities : |
C/C, Hypothecation |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
D. J. Mehta and Company Chartered Accountants |
|
Address : |
3, Sharda Estate, L.T. Road, Borivali [West], Mumbai 400092,
Maharashtra, India |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs. 10/- each |
Rs. 10.000 Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
700000 |
Equity Shares |
Rs. 10/-
each |
Rs. 7.000
Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
7.000 |
7.000 |
5.000 |
|
|
2] Share Application Money |
8.100 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
2.955 |
1.904 |
0.000 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
[0.124] |
|
|
NETWORTH |
18.055 |
8.904 |
4.876 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
13.165 |
6.192 |
9.187 |
|
|
2] Unsecured Loans |
3.763 |
3.626 |
15.796 |
|
|
TOTAL BORROWING |
16.928 |
9.818 |
24.983 |
|
|
DEFERRED TAX LIABILITIES |
0.217 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
35.200 |
18.722 |
29.859 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
21.499 |
18.652 |
19.866 |
|
|
Capital work-in-progress |
0.000 |
0.379 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.017 |
0.017 |
0.017 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
12.007
|
8.496 |
5.215 |
|
|
Sundry Debtors |
11.522
|
8.404 |
5.077 |
|
|
Cash & Bank Balances |
0.839
|
0.085 |
0.066 |
|
|
Other Current Assets |
0.025
|
0.025 |
0.025 |
|
|
Loans & Advances |
10.450
|
10.226 |
3.030 |
|
Total
Current Assets |
34.843
|
27.236 |
13.413 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
20.304
|
27.340 |
3.399 |
|
|
Provisions |
0.871
|
0.240 |
0.038 |
|
Total
Current Liabilities |
21.175
|
27.580 |
3.437 |
|
|
Net Current Assets |
13.668
|
[0.344] |
9.976 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.016 |
0.018 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
35.200 |
18.722 |
29.859 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
NA
|
NA |
NA |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
NA |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
NA
|
NA |
NA |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
NA
|
NA |
NA |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.11
|
4.20 |
5.82 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.65
|
0.98 |
3.90 |
LOCAL AGENCY
FURTHER INFORMATION
Trade References:
- Kaknar,
Turkey
- Qvali Pharma
OTHER
INFORMATION:-
|
PARAMETER |
DETAIL |
|
|
|
|
Statutory
Approval |
|
|
Income Tax Registration |
AABCM8349L |
|
VAT / TIN Registration |
27060401592 |
|
Import Export Code |
0396051049 |
|
Name of Bank |
Bank of Baroda |
|
Current Account Number |
04200500000027 |
|
|
|
|
Standard and
certifications |
|
|
Quality Management Systems |
ISO 9001:2000 No:1261 |
Form 8
Bankers Charges
Report as per Registry
|
This form is for |
Modification of
charge |
|
Charge identification
number of the charge to be modified |
80024471 |
|
Corporate
identity number of the company |
U24230MH1994PTC077187 |
|
Name of the
company |
MEDICO REMEDIES
PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in India of the company |
50, Juhu Supreme Shopping Center, Gulmohar Cross Road No. 9, Juhu,
Mumbai 400049, Maharashtra, India |
|
Type of charge |
|
|
Particular of
charge holder |
Bank of Baroda Vile Parle [West]
Branch, Somaiya Sadan, D. J. Road, Mumbai 400056, Maharashtra, India |
|
Nature of
description of the instrument creating or modifying the charge |
Hypothecation
Agreement |
|
Date of
instrument Creating the charge |
23.02.2007 |
|
Amount secured by
the charge |
Rs. 12.437
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
[a] Rate of
interest 1% over PLR 13.5%
p.a. with monthly rest on Cash credit 3.75% over PLR
min. 16.25% p.a. with monthly rests on Term Loan I and II As per extent of
guidelines on PC/FBP/PSDL [90 days] [b] Terms of
repayment On demand [c] Margin 35% on Cash
Credit 25% on Term loans 255 for Packing
Credit and for FBP/UFBP [d] Extent and
operation of the charge The charge is
created to secure Cash Credit Rs. 4.000 Millions. PC/FBP/UFBP/PSDL – Rs.
7.500 Millions, Term Loan Rs. 0.110 Millions and Term Loan II – Rs. 0.827
Millions |
|
Short particulars
of the property charged |
Stocks, both
present and future including all stocks of RMs, WIP, SFGs and FGs such as
Medicines, Capsules, Tablets, Raw Materials and Packing Materials and stores
etc. and all the present and future book debts, outstanding monies
receivables, claims, bills, contracts, engagements and securities etc. And
all the tangible movable machinery and plant and cranes, boat and crafts and
the vehicles of the Borrower together with spares, tools and accessories and
other movables, both present and future. |
|
Date of latest
modification |
29.06.2005 |
|
Particulars of
the present modification |
The charge is now
modified upto Rs. 12.437 Millions to cover cash credit Rs. 4.000 Millions
PC/FBP/UFBP/PSDL – Rs. 7.500 Millions, Term loan Rs. 0.110 Million and Term
Loan II Rs. 0.827 Millions |
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 42.59 |
|
UK Pound |
1 |
Rs. 84.16 |
|
Euro |
1 |
Rs. 65.99 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|